Telomere Lengths, Pulmonary Fibrosis and Telomerase (TERT) Mutations
Open accessThe DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Telomerase is an enzyme that catalyzes the addition of nucleotides on the ends of chromosomes. Rare loss of function mutations in the gene that encodes the protein component of telomerase (TERT) have been described in patients with idiopathic pulmonary fibrosis (IPF). Here we examine the telomere lengths and pulmonary fibrosis phenotype seen in multiple kindreds with heterozygous TERT mutations. METHODS AND FINDINGS: We have identified 134 individuals with heterozygous TERT mutations from 21 unrelated families. Available medical records, surgical lung biopsies and radiographs were evaluated retrospectively. Genomic DNA isolated from circulating leukocytes has been used to measure telomere lengths with a quantitative PCR assay. We find that telomere lengths of TERT mutation carriers decrease in an age-dependent manner and show progressive shortening with successive generations of mutation inheritance. Family members without TERT mutations have a shorter mean telomere length than normal, demonstrating epigenetic inheritance of shortened telomere lengths in the absence of an inherited TERT mutation. Pulmonary fibrosis is an age-dependent phenotype not seen in mutation carriers less than 40 years of age but found in 60% of men 60 years or older; its development is associated with environmental exposures including cigarette smoking. A radiographic CT pattern of usual interstitial pneumonia (UIP), which is consistent with a diagnosis of IPF, is seen in 74% of cases and a pathologic pattern of UIP is seen in 86% of surgical lung biopsies. Pulmonary fibrosis associated with TERT mutations is progressive and lethal with a mean survival of 3 years after diagnosis. Overall, TERT mutation carriers demonstrate reduced life expectancy, with a mean age of death of 58 and 67 years for males and females, respectively. CONCLUSIONS: A subset of pulmonary fibrosis, like dyskeratosis congenita, bone marrow failure, and liver disease, represents a "telomeropathy" caused by germline mutations in telomerase and characterized by short telomere lengths. Family members within kindreds who do not inherit the TERT mutation have shorter telomere lengths than controls, demonstrating epigenetic inheritance of a shortened parental telomere length set-point.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In IPF patients with telomerase mutations, the mean age of onset is 51 years, although IPF can manifest as late as the ninth decade of life70,71.”
From The telomere syndromes (2012) · cites this paper as [70]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition, both dyskeratosis congenita and IPF patients are prone to developing haematological malignancies, commonly manifesting as myelodysplasia or acute myeloid leukaemia70,75,76.”
From The telomere syndromes (2012) · cites this paper as [70]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091 · cited 1×
“hTERT is highly expressed in germ cells, cells with proliferative potential and immortalized cancer cells[3,4,5].”
Background(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.2.ats01 · Cited by 4,196
Identification of a specific telomere terminal transferase activity in tetrahymena extracts
Greider, C. W., & Blackburn, E. H. (1985) · Cell · doi:10.1016/0092-8674(85)90170-9 · Cited by 3,400 · cited 1×
“The human enzyme consists of both a functional RNA (hTR) and a reverse transcriptase protein component (hTERT)[1,2].”
BackgroundThe RNA Component of Human Telomerase
Feng, J., Funk, W. D., Wang, S.-S., Weinrich, S. L., Avilion, A. A., Chiu, C.-P., Adams, R. R., Chang, E., Allsopp, R. C., Yu, J., et al. (1995) · Science · doi:10.1126/science.7544491 · Cited by 2,227 · cited 1×
“The human enzyme consists of both a functional RNA (hTR) and a reverse transcriptase protein component (hTERT)[1,2].”
BackgroundTelomere reduction in human colorectal carcinoma and with ageing
Hastie, N. D., Dempster, M., Dunlop, M. G., Thompson, A. M., Green, D. K., & Allshire, R. C. (1990) · Nature · doi:10.1038/346866a0 · Cited by 1,650 · cited 1×
“Evidence of this is seen by the progressive shortening of telomere lengths of human mononuclear leukocytes with age[6] and several diseases of inherited telomerase dysfunction[7].”
BackgroundTelomere length measurement by a novel monochrome multiplex quantitative PCR method
Cawthon, R. M. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn1027 · Cited by 1,410 · cited 1×
“Multiplexed quantitative polymerase chain reaction (PCR) determination of telomere lengths were performed on a RotorGene real-time PCR system (Qiagen) as described[21] with 0.”
MethodTelomerase Mutations in Families with Idiopathic Pulmonary Fibrosis
Armanios, M. Y., Chen, J. J.-L., Cogan, J. D., Alder, J. K., Ingersoll, R. G., Markin, C., Lawson, W. E., Xie, M., Vulto, I., Phillips, J. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066157 · Cited by 1,357 · cited 1×
“Heterozygous loss-offunction mutations in TERT have been found in up to 15% of kindreds with the familial pulmonary fibrosis[17,18] and in 1–3% of sporadic cases[19,20].”
BackgroundIncidence and Prevalence of Idiopathic Pulmonary Fibrosis
Raghu, G., Weycker, D., Edelsberg, J., Bradford, W. Z., & Oster, G. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200602-163oc · Cited by 1,310 · cited 1×
“However, unlike DKC, IPF is much more common with its prevalence increasing with age to 65 cases per 100,000 for those 75 years or older [16].”
BackgroundSelf-citationHeiss, N. S., Knight, S. W., Vulliamy, T. J., Klauck, S. M., Wiemann, S., Mason, P. J., Poustka, A., & Dokal, I. (1998) · Nature Genetics · doi:10.1038/ng0598-32 · Cited by 976 · cited 1×
“Most DKC patients have mutations in the X-linked DKC1 gene, which encodes dyskerin[8]; fewer patients have mutations in TERC, which encodes hTR[9].”
BackgroundThe RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita
Vulliamy, T., Marrone, A., Goldman, F., Dearlove, A., Bessler, M., Mason, P. J., & Dokal, I. (2001) · Nature · doi:10.1038/35096585 · Cited by 960 · cited 1×
“Most DKC patients have mutations in the X-linked DKC1 gene, which encodes dyskerin[8]; fewer patients have mutations in TERC, which encodes hTR[9].”
Background
Cited by
Armanios, M., & Blackburn, E. H. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3246 · Cited by 982
Telomeres and telomerase: three decades of progress
Shay, J. W., & Wright, W. E. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-019-0099-1 · Cited by 924
Stuart, B. D., Choi, J., Zaidi, S., Xing, C., Holohan, B., Chen, R., Choi, M., Dharwadkar, P., Torres, F., Girod, C. E., et al. (2015) · Nature Genetics · doi:10.1038/ng.3278 · Cited by 469
Self-citationEmerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease
Mora, A. L., Rojas, M., Pardo, A., & Selman, M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.170 · Cited by 402
Telomere-related lung fibrosis is diagnostically heterogeneous but uniformly progressive
Newton, C. A., Batra, K., Torrealba, J., Kozlitina, J., Glazer, C. S., Aravena, C., Meyer, K., Raghu, G., Collard, H. R., & Garcia, C. K. (2016) · European Respiratory Journal · doi:10.1183/13993003.00308-2016 · Cited by 400
“Telomere lengths of genomic DNA from circulating leukocytes were measured using a quantitative PCR assay as previously described [3, 5, 8] and are represented as a logarithm-transformed relative ratio of telomeres to a single copy gene (T/S) or an age-adjusted telomere length.”
BackgroundMethodSelf-citationIdiopathic Pulmonary Fibrosis (IPF): An Overview
Barratt, S., Creamer, A., Hayton, C., & Chaudhuri, N. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7080201 · Cited by 382
Alveolar Epithelial Type II Cells as Drivers of Lung Fibrosis in Idiopathic Pulmonary Fibrosis
Parimon, T., Yao, C., Stripp, B. R., Noble, P. W., & Chen, P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072269 · Cited by 375
Macrophages: friend or foe in idiopathic pulmonary fibrosis?
Zhang, L., Wang, Y., Wu, G., Xiong, W., Gu, W., & Wang, C.-Y. (2018) · Respiratory Research · doi:10.1186/s12931-018-0864-2 · Cited by 375
“Past genetic studies in familial and sporadic IPF patients have characterized that the surfactant-associated genes (surfactant protein C, SFTPC; surfactant protein A2, SFTPA2; and ATP binding cassette member A3, ABCA3) [10, 11] and the telomerase-related genes (telomerase reverse transcriptase, TERT; telomerase RNA co…”
BackgroundTelomeres and age-related disease: how telomere biology informs clinical paradigms
Armanios, M. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66370 · Cited by 347
Telomere dysfunction causes alveolar stem cell failure
Alder, J. K., Barkauskas, C. E., Limjunyawong, N., Stanley, S. E., Kembou, F., Tuder, R. M., Hogan, B. L. M., Mitzner, W., & Armanios, M. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1504780112 · Cited by 339
Epidemiology of idiopathic pulmonary fibrosis
Ley, B., & Collard, H. (2013) · Clinical Epidemiology · doi:10.2147/clep.s54815 · Cited by 321
Chilosi, M., Carloni, A., Rossi, A., & Poletti, V. (2013) · Translational Research · doi:10.1016/j.trsl.2013.06.004 · Cited by 317
Stuart, B. D., Lee, J. S., Kozlitina, J., Noth, I., Devine, M. S., Glazer, C. S., Torres, F., Kaza, V., Girod, C. E., Jones, K. D., et al. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70124-9 · Cited by 310
Self-citationAcute exacerbation of idiopathic pulmonary fibrosis associated with air pollution exposure
Johannson, K. A., Vittinghoff, E., Lee, K., Balmes, J. R., Ji, W., Kaplan, G. G., Kim, D. S., & Collard, H. R. (2014) · European Respiratory Journal · doi:10.1183/09031936.00122213 · Cited by 295
“mechanistic relationship between air pollution exposure and the development of pulmonary fibrosis.(12-14) We hypothesized that the risk of acute exacerbations in patients with IPF would be higher following periods of increased air pollution exposure.”
BackgroundLey, B., Newton, C. A., Arnould, I., Elicker, B. M., Henry, T. S., Vittinghoff, E., Golden, J. A., Jones, K. D., Batra, K., Torrealba, J., et al. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30216-3 · Cited by 296
“001 Mild (< 10%) 39 (33) 21 (30) Moderate (10–50%) 49 (41) 27 (39) Severe (> 50%) 6 (5) 18 (26) Honeycombing, n (%) 18 (15) 24 (34) 0.”
Self-citationBone marrow failure and the telomeropathies
Townsley, D. M., Dumitriu, B., & Young, N. S. (2014) · Blood · doi:10.1182/blood-2014-05-526285 · Cited by 291
The pathogenesis of idiopathic pulmonary fibrosis
Coward, W. R., Saini, G., & Jenkins, G. (2010) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753465810379801 · Cited by 272
Telomere dysfunction in alveolar epithelial cells causes lung remodeling and fibrosis
Naikawadi, R. P., Disayabutr, S., Mallavia, B., Donne, M. L., Green, G., La, J. L., Rock, J. R., Looney, M. R., & Wolters, P. J. (2016) · JCI Insight · doi:10.1172/jci.insight.86704 · Cited by 267
Dokal, I. (2011) · Hematology · doi:10.1182/asheducation-2011.1.480 · Cited by 266
Telomere Length Is a Determinant of Emphysema Susceptibility
Alder, J. K., Guo, N., Kembou, F., Parry, E. M., Anderson, C. J., Gorgy, A. I., Walsh, M. F., Sussan, T., Biswal, S., Mitzner, W., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201103-0520oc · Cited by 265
“Young-onset emphysema in telomerase mutation carriers Telomerase mutations are a risk factor for IPF, but heterogeneous pulmonary disease phenotypes have been seen in telomerase mutation carriers(18, 38, 39).”
BackgroundDiseases of Pulmonary Surfactant Homeostasis
Whitsett, J. A., Wert, S. E., & Weaver, T. E. (2015) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012513-104644 · Cited by 256
“It is a progressive, lethal disease with a mean life expectancy of 3 years after diagnosis (125).”
BackgroundTelomerase and idiopathic pulmonary fibrosis
Armanios, M. (2012) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2011.10.013 · Cited by 245
“The requirement for additional hits may explain why mutant telomerase genes in IPF patients manifest late in life where the average age of onset is in the sixth decade[26, 42, 43].”
BackgroundInfluentialMitochondria in the spotlight of aging and idiopathic pulmonary fibrosis
Mora, A. L., Bueno, M., & Rojas, M. (2017) · Journal of Clinical Investigation · doi:10.1172/jci87440 · Cited by 235
Juge, P.-A., Borie, R., Kannengiesser, C., Gazal, S., Revy, P., Wemeau-Stervinou, L., Debray, M.-P., Ottaviani, S., Marchand-Adam, S., Nathan, N., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.02314-2016 · Cited by 232
Dongiovanni, P., Anstee, Q., & Valenti, L. (2013) · Current Pharmaceutical Design · doi:10.2174/13816128113199990381 · Cited by 233
Ballew, B. J., & Savage, S. A. (2013) · Expert Review of Hematology · doi:10.1586/ehm.13.23 · Cited by 209
Luppi, F., Kalluri, M., Faverio, P., Kreuter, M., & Ferrara, G. (2021) · Respiratory Research · doi:10.1186/s12931-021-01711-1 · Cited by 194
“smoking is present in over two-thirds of affected patients with these mutations [36].”
BackgroundRare Variants in RTEL1 Are Associated with Familial Interstitial Pneumonia
Cogan, J. D., Kropski, J. A., Zhao, M., Mitchell, D. B., Rives, L., Markin, C., Garnett, E. T., Montgomery, K. H., Mason, W. R., McKean, D. F., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201408-1510oc · Cited by 196
“1), as has been previously reported in families with TERT mutations associated with short telomeres (27).”
BackgroundTelomerase mutations in smokers with severe emphysema
Stanley, S. E., Chen, J. J. L., Podlevsky, J. D., Alder, J. K., Hansel, N. N., Mathias, R. A., Qi, X., Rafaels, N. M., Wise, R. A., Silverman, E. K., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci78554 · Cited by 196
The genetic basis of idiopathic pulmonary fibrosis
Kropski, J. A., Blackwell, T. S., & Loyd, J. E. (2015) · European Respiratory Journal · doi:10.1183/09031936.00163814 · Cited by 193
Lung transplantation in telomerase mutation carriers with pulmonary fibrosis
Silhan, L. L., Shah, P. D., Chambers, D. C., Snyder, L. D., Riise, G. C., Wagner, C. L., Hellström-Lindberg, E., Orens, J. B., Mewton, J. F., Danoff, S. K., et al. (2014) · European Respiratory Journal · doi:10.1183/09031936.00060014 · Cited by 192
Prevalence and characteristics of TERT and TERC mutations in suspected genetic pulmonary fibrosis
Borie, R., Tabèze, L., Thabut, G., Nunes, H., Cottin, V., Marchand-Adam, S., Prevot, G., Tazi, A., Cadranel, J., Mal, H., et al. (2016) · European Respiratory Journal · doi:10.1183/13993003.02115-2015 · Cited by 184
The pathogenesis of COPD and IPF: Distinct horns of the same devil?
Chilosi, M., Poletti, V., & Rossi, A. (2012) · Respiratory Research · doi:10.1186/1465-9921-13-3 · Cited by 183
Niewisch, M. R., & Savage, S. A. (2019) · Expert Review of Hematology · doi:10.1080/17474086.2019.1662720 · Cited by 174
“ifest in late adulthood,with amedian age of onset between 50 and 60 years of age [13,132].”
BackgroundTelomere Length and Use of Immunosuppressive Medications in Idiopathic Pulmonary Fibrosis
Newton, C. A., Zhang, D., Oldham, J. M., Kozlitina, J., Ma, S.-F., Martinez, F. J., Raghu, G., Noth, I., & Garcia, C. K. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201809-1646oc · Cited by 173
“The LTL was measured at UTSW for all samples using a quantitative polymerase chain assay and the RotoGene real-time PCR system (Qiagen) as previously described (12, 14, 32).”
MethodSelf-citationMolecular Mechanisms of Pulmonary Fibrogenesis and Its Progression to Lung Cancer: A Review
Kinoshita, T., & Goto, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061461 · Cited by 176
Telomeropathies: An emerging spectrum disorder
Holohan, B., Wright, W. E., & Shay, J. W. (2014) · Journal of Cell Biology · doi:10.1083/jcb.201401012 · Cited by 175
“Many groups have noted that the telomeropathies resemble a spectrum disorder much more than distinct diseases (Carroll and Ly, 2009; Diaz de Leon et al., 2010; Armanios and Blackburn, 2012); however, the current nomenclature does not reflect this property of telomeropathies.”
InfluentialNewton, C. A., Oldham, J. M., Ley, B., Anand, V., Adegunsoye, A., Liu, G., Batra, K., Torrealba, J., Kozlitina, J., Glazer, C., et al. (2019) · European Respiratory Journal · doi:10.1183/13993003.01641-2018 · Cited by 174
Self-citationA method for measuring the distribution of the shortest telomeres in cells and tissues
Lai, T.-P., Zhang, N., Noh, J., Mender, I., Tedone, E., Huang, E., Wright, W. E., Danuser, G., & Shay, J. W. (2017) · Nature Communications · doi:10.1038/s41467-017-01291-z · Cited by 163
The molecular genetics of the telomere biology disorders
Bertuch, A. A. (2016) · RNA Biology · doi:10.1080/15476286.2015.1094596 · Cited by 169
“The mutation, V114M, maps to the TEN domain and was identified in 2 kinships with IPF and blood dyscrasias.(100)”
BackgroundCommon pathways in idiopathic pulmonary fibrosis and cancer
Vancheri, C. (2013) · European Respiratory Review · doi:10.1183/09059180.00003613 · Cited by 166
Heterozygous RTEL1 mutations are associated with familial pulmonary fibrosis
Kannengiesser, C., Borie, R., Ménard, C., Réocreux, M., Nitschké, P., Gazal, S., Mal, H., Taillé, C., Cadranel, J., Nunes, H., et al. (2015) · European Respiratory Journal · doi:10.1183/09031936.00040115 · Cited by 162
Conti, S., Harari, S., Caminati, A., Zanobetti, A., Schwartz, J. D., Bertazzi, P. A., Cesana, G., & Madotto, F. (2018) · European Respiratory Journal · doi:10.1183/13993003.00397-2017 · Cited by 147
Borie, R., Kannengiesser, C., Hirschi, S., Le Pavec, J., Mal, H., Bergot, E., Jouneau, S., Naccache, J.-M., Revy, P., Boutboul, D., et al. (2015) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2014.11.010 · Cited by 143
“Thrombocytopenia worsened after lung transplantation in 5/7 patients who had thrombocytopenia prior to the transplantation, reaching a platelets count of 25 G/L [8-28].”
BackgroundInfluentialHumidifier Disinfectant–associated Children’s Interstitial Lung Disease
Kim, K. W., Ahn, K., Yang, H. J., Lee, S., Park, J. D., Kim, W. K., Kim, J.-T., Kim, H. H., Rha, Y.-H., Park, Y. M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201306-1088oc · Cited by 142
Newton, C. A., Kozlitina, J., Lines, J. R., Kaza, V., Torres, F., & Garcia, C. K. (2017) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2017.02.005 · Cited by 132
Self-citationEuropean Respiratory Society statement on familial pulmonary fibrosis
Borie, R., Kannengiesser, C., Antoniou, K. M., Bonella, F., Crestani, B., Fabre, A., Froidure, A., Galvin, L., Griese, M., Grutters, J. C., et al. (2022) · European Respiratory Journal · doi:10.1183/13993003.01383-2022 · Cited by 147
“A typical UIP pattern on chest CT was initially reported in up to 74% of ILD cases with TRG mutations, but was subsequently found in only 46 – 55% of cases [8, 10, 31].”
BackgroundInfluentialIdiopathic Pulmonary Fibrosis: Update on Genetic Discoveries
Garcia, C. K. (2011) · Proceedings of the American Thoracic Society · doi:10.1513/pats.201008-056ms · Cited by 126
“The V144M and the R951W mutations have been found in unrelated kindreds (26).”
BackgroundMethodSelf-citationTelomere-mediated lung disease
Alder, J. K., & Armanios, M. (2022) · Physiological Reviews · doi:10.1152/physrev.00046.2021 · Cited by 130
Beginning at the ends: telomeres and human disease
Savage, S. A. (2018) · F1000Research · doi:10.12688/f1000research.14068.1 · Cited by 124
Ley, B., Torgerson, D. G., Oldham, J. M., Adegunsoye, A., Liu, S., Li, J., Elicker, B. M., Henry, T. S., Golden, J. A., Jones, K. D., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201902-0360oc · Cited by 125
“, TERT R951W [32], H412Y [33], A716T [34], and H592N [35]; RTEL1 R957Q [36]; and DKC1 S280R [37]) have been reported in patients with diseases recognized to be caused by telomere dysfunction (see also Table E5).”
BackgroundProgress in Understanding and Treating Idiopathic Pulmonary Fibrosis
Kropski, J. A., & Blackwell, T. S. (2019) · Annual Review of Medicine · doi:10.1146/annurev-med-041317-102715 · Cited by 137
Erratum: Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease
Mora, A. L., Rojas, M., Pardo, A., & Selman, M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.225 · Cited by 128
Alder, J. K., Cogan, J. D., Brown, A. F., Anderson, C. J., Lawson, W. E., Lansdorp, P. M., Phillips, J. A., Loyd, J. E., Chen, J. J.-L., & Armanios, M. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1001352 · Cited by 119
Guo, Y., Kartawinata, M., Li, J., Pickett, H. A., Teo, J., Kilo, T., Barbaro, P. M., Keating, B., Chen, Y., Tian, L., et al. (2014) · Blood · doi:10.1182/blood-2014-08-596445 · Cited by 120
“with inherited idiopathic pulmonary fibrosis, short telomeres, and hTERT mutations also frequently contain members with leukemia and other malignancies.(66,70,71) It is likely that inherited short telomeres can lead to chromosome fusions and genetic instability, which predisposes to malignancy.”
BackgroundPulmonary fibrosis: pathogenesis and therapeutic strategies
Wang, J., Li, K., Hao, D., Li, X., Zhu, Y., Yu, H., & Chen, H. (2024) · MedComm · doi:10.1002/mco2.744 · Cited by 149
Althobiani, M. A., Russell, A., Jacob, J., Ranjan, Y., Folarin, A., Hurst, J. R., & Porter, J. C. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1296890 · Cited by 147
Cell senescence and fibrotic lung diseases
Liu, R.-M., & Liu, G. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.110836 · Cited by 113
Idiopathic Pulmonary Fibrosis: From Epithelial Injury to Biomarkers - Insights from the Bench Side
Kolb, Borensztajn, K., Crestani, B., & Kolb, M. (2013) · Respiration · doi:10.1159/000357598 · Cited by 113
Smoking and Idiopathic Pulmonary Fibrosis
Oh, C. K., Murray, L. A., & Molfino, N. A. (2012) · Pulmonary Medicine · doi:10.1155/2012/808260 · Cited by 132
de Leon, A. D., Cronkhite, J. T., Yılmaz, C., Brewington, C. C., Wang, R. C., Xing, C., Hsia, C. C. W., & Garcia, C. K. (2011) · CHEST Journal · doi:10.1378/chest.10-2865 · Cited by 116
Self-citationLung cancer is also a hereditary disease
Benusiglio, P. R., Fallet, V., Sanchis-Borja, M., Coulet, F., & Cadranel, J. L. (2021) · European Respiratory Review · doi:10.1183/16000617.0045-2021 · Cited by 126
Clinical outcomes of lung transplant recipients with telomerase mutations
Tokman, S., Singer, J. P., Devine, M. S., Westall, G. P., Aubert, J.-D., Tamm, M., Snell, G. I., Lee, J. S., Goldberg, H. J., Kukreja, J., et al. (2015) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2015.05.002 · Cited by 109
Self-citationVulliamy, T. J., Kirwan, M. J., Beswick, R., Hossain, U., Baqai, C., Ratcliffe, A., Marsh, J., Walne, A., & Dokal, I. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024383 · Cited by 105
Disease progression and clinical outcomes in telomere biology disorders
Niewisch, M. R., Giri, N., McReynolds, L. J., Alsaggaf, R., Bhala, S., Alter, B. P., & Savage, S. A. (2022) · Blood · doi:10.1182/blood.2021013523 · Cited by 103
Short Telomere Syndromes in Clinical Practice: Bridging Bench and Bedside
Mangaonkar, A. A., & Patnaik, M. M. (2018) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2018.03.020 · Cited by 98
Fernandez, B. A., Fox, G. A., Bhatia, R., Sala, E., Noble, B., Denic, N., Fernandez, D., Duguid, N., Dohey, A., Kamel, F., et al. (2012) · Respiratory Research · doi:10.1186/1465-9921-13-64 · Cited by 108
“PF never occurred before age 40, and developed in 60% of male mutation carriers by age 60 [31].”
BackgroundIdiopathic pulmonary fibrosis and cancer: do they really look similar?
Vancheri, C. (2015) · BMC Medicine · doi:10.1186/s12916-015-0478-1 · Cited by 94
“(h-TERT and h-TERC) and a subsequent shortening of telomeres have also been described [14–17].”
BackgroundGenetic Evaluation and Testing of Patients and Families with Idiopathic Pulmonary Fibrosis
Kropski, J. A., Young, L. R., Cogan, J. D., Mitchell, D. B., LANCASTER, L. H., Worrell, J. A., Markin, C. R., Liu, N., Mason, W. R., Fingerlin, T. E., et al. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201609-1820pp · Cited by 103
“Of note, telomere length can be inherited independently from a culprit rare genetic variant, and thus it is possible to inherit short telomeres (and disease risk) without inheriting a mutation; this has been termed “occult genetic disease” (25, 26).”
BackgroundInfluence of age on wound healing and fibrosis
Kapetanaki, M. G., Mora, A. L., & Rojas, M. (2013) · The Journal of Pathology · doi:10.1002/path.4122 · Cited by 90
Cottin, V., & Richeldi, L. (2014) · European Respiratory Review · doi:10.1183/09059180.00008613 · Cited by 89
Doyle, T. J., Lee, J. S., Dellaripa, P. F., Lederer, J. A., Matteson, E. L., Fischer, A., Ascherman, D. P., Glassberg, M. K., Ryu, J. H., Danoff, S. K., et al. (2014) · CHEST Journal · doi:10.1378/chest.13-2408 · Cited by 99
Telomeres and immune competency
Weng, N.-P. (2012) · Current Opinion in Immunology · doi:10.1016/j.coi.2012.05.001 · Cited by 87
“In addition, genetic mutations of telomerase components, with consequent short telomeres, have also been found in association with idiopathic fibrosis of lung [15], fibrosis/cirrhosis of liver [16,17], and hereditary cancer risk [18].”
Cellular Senescence: The Trojan Horse in Chronic Lung Diseases
Hamsanathan, S., Alder, J. K., Sellares, J., Rojas, M., Gurkar, A. U., & Mora, A. L. (2019) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2018-0410tr · Cited by 86
Telomeres in Interstitial Lung Disease: The Short and the Long of It
Courtwright, A., & El‐Chemaly, S. (2018) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201808-508cme · Cited by 88
S2K-Leitlinie zur Diagnostik und Therapie der idiopathischen Lungenfibrose
Behr, J., Günther, A., Ammenwerth, W., Bittmann, I., Bonnet, R. B., Buhl, R., Eickelberg, O., Ewert, R., Gläser, S., Gottlieb, J., et al. (2013) · Pneumologie · doi:10.1055/s-0032-1326009 · Cited by 110
“Die familiäre Form der IIP mit UIP-Muster hat eine ähnlich schlechte Prognose wie die sporadische IPF [94].”
Katzenstein, A.-L. A. (2012) · Modern Pathology · doi:10.1038/modpathol.2011.154 · Cited by 88
Self-citationTelomere length and immunosuppression in non-idiopathic pulmonary fibrosis interstitial lung disease
Zhang, D., Adegunsoye, A., Oldham, J. M., Kozlitina, J., Garcia, N. M., Poonawalla, M., Strykowski, R. K., Linderholm, A., Ley, B., Ma, S., et al. (2023) · European Respiratory Journal · doi:10.1183/13993003.00441-2023 · Cited by 95
“All LTLs were measured using a similar quantitative PCR (qPCR) methodology at either UTSW/CUMC (discovery cohort) or UCSF (replication cohort) as previously reported [19, 21, 23, 24].”
Self-citationSomatic mutations in telomerase promoter counterbalance germline loss-of-function mutations
Maryoung, L., Yue, Y., Young, A., Newton, C. A., Barba, C., van Oers, N. S. C., Wang, R. C., & Garcia, C. K. (2017) · Journal of Clinical Investigation · doi:10.1172/jci91161 · Cited by 87
“Three germline TERT missense alleles, Lys570Asn, Arg631Gln, and Arg865His, are associated with a severe reduction of telomerase activity and processivity (8, 12, 13).”
BackgroundSelf-citationLung Transplant Outcomes in Patients With Pulmonary Fibrosis With Telomere-Related Gene Variants
Swaminathan, A. C., Neely, M. L., Frankel, C. W., Kelly, F. L., Petrovski, S., Durheim, M. T., Bush, E., Snyder, L. D., Goldstein, D. B., Todd, J. L., et al. (2019) · CHEST Journal · doi:10.1016/j.chest.2019.03.030 · Cited by 85
Le Saux, C. J., Davy, P., Brampton, C., Ahuja, S. S., Fauce, S., Shivshankar, P., Nguyen, H., Ramaseshan, M., Tressler, R., Pirot, Z., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058423 · Cited by 82
Management of suspected monogenic lung fibrosis in a specialised centre
Borie, R., Kannengiesser, C., de Fontbrune, F. S., Gouya, L., Nathan, N., & Crestani, B. (2017) · European Respiratory Review · doi:10.1183/16000617.0122-2016 · Cited by 88
Association between MUC5B and TERT polymorphisms and different interstitial lung disease phenotypes
Wei, R., Li, C., Zhang, M., Jones-Hall, Y. L., Myers, J. L., Noth, I., & Liu, W. (2014) · Translational Research · doi:10.1016/j.trsl.2013.12.006 · Cited by 80
Genomic Characterization of the Inherited Bone Marrow Failure Syndromes
Khincha, P. P., & Savage, S. A. (2013) · Seminars in Hematology · doi:10.1053/j.seminhematol.2013.09.002 · Cited by 78
“Subsequently, a combination of linkage (48) and candidate gene sequencing found mutations in TERT, as a cause of DC as well as in cases of isolated aplastic anemia and pulmonary fibrosis (49-52).”
BackgroundCellular Senescence in Lung Fibrosis
Hernandez-Gonzalez, F., Faner, R., Rojas, M., Agustí, A., Serrano, M., & Sellarés, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137012 · Cited by 76
Chung, J. H., Zhan, X., Cao, M., Koelsch, T. L., Manjarres, D. C. G., Brown, K. K., Lynch, D. A., Russell, G., & Pérez, E. R. F. (2017) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201701-035oc · Cited by 78
Pulmonary fibrosis in the era of stratified medicine
Mathai, S. K., Newton, C. A., Schwartz, D. A., & Garcia, C. K. (2016) · Thorax · doi:10.1136/thoraxjnl-2016-209172 · Cited by 77
Self-citationNeglected evidence in idiopathic pulmonary fibrosis: from history to earlier diagnosis
Cordier, J.-F., & Cottin, V. (2013) · European Respiratory Journal · doi:10.1183/09031936.00027913 · Cited by 78
Human Telomeres and Telomere Biology Disorders
Savage, S. A. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-397898-1.00002-5 · Cited by 81
Genetics of idiopathic pulmonary fibrosis: from mechanistic pathways to personalised medicine
Spagnolo, P., & Cottin, V. (2016) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2016-103973 · Cited by 82
Adegunsoye, A., Kropski, J. A., Behr, J., Blackwell, T. S., Corte, T. J., Cottin, V., Glanville, A. R., Glassberg, M. K., Griese, M., Hunninghake, G. M., et al. (2024) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202401-0238so · Cited by 97
Sivley, R. M., Kropski, J., Sheehan, J., Cogan, J., Dou, X., Blackwell, T. S., Phillips, J., Meiler, J., Bush, W. S., & Capra, J. A. (2018) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2018.01.017 · Cited by 79
Defective telomere elongation and hematopoiesis from telomerase-mutant aplastic anemia iPSCs
Winkler, T., Hong, S. G., Decker, J. E., Morgan, M. J., Wu, C., Hughes, W. M., Yang, Y., Wangsa, D., Padilla-Nash, H. M., Ried, T., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67146 · Cited by 72
“…patients bearing TERT or TERC mutations present with disease later in life, often only a single organ is affected, and family members with the same mutation may be clinically normal (3, 10, 37); they have isolated aplastic anemia or pulmonary fibrosis without apparent involvement of other organs.”
Understanding COPD-overlap syndromes
Poh, T. Y., Aogáin, M. M., Chan, A., Yii, A. C. A., Yong, V. F. L., Tiew, P. Y., Koh, M. S., & Chotirmall, S. H. (2017) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2017.1305895 · Cited by 73
MUC5B variant is associated with visually and quantitatively detected preclinical pulmonary fibrosis
Mathai, S. K., Humphries, S. M., Kropski, J. A., Blackwell, T. S., Powers, J., Walts, A. D., Markin, C. R., Woodward, J., Chung, J. H., Brown, K. K., et al. (2019) · Thorax · doi:10.1136/thoraxjnl-2018-212430 · Cited by 83
The biology and management of dyskeratosis congenita and related disorders of telomeres
Tummala, H., Walne, A. J., & Dokal, I. S. (2022) · Expert Review of Hematology · doi:10.1080/17474086.2022.2108784 · Cited by 75
Integrating Genomics Into Management of Fibrotic Interstitial Lung Disease
Adegunsoye, A., Vij, R., & Noth, I. (2019) · CHEST Journal · doi:10.1016/j.chest.2018.12.011 · Cited by 80
Giri, N., Lee, R. L., Faro, A., Huddleston, C. B., White, F. V., Alter, B. P., & Savage, S. A. (2011) · BMC Blood Disorders · doi:10.1186/1471-2326-11-3 · Cited by 70
Borie, R., Bouvry, D., Cottin, V., Gauvain, C., Cazes, A., Debray, M., Cadranel, J. L., Dieudé, P., Dégot, T., Dominique, S., et al. (2018) · European Respiratory Journal · doi:10.1183/13993003.00508-2018 · Cited by 76
The genetics of interstitial lung diseases
Borie, R., Guen, P. L., Ghanem, M., Taillé, C., Dupin, C., Dieudé, P., Kannengiesser, C., & Crestani, B. (2019) · European Respiratory Review · doi:10.1183/16000617.0053-2019 · Cited by 79
Metadata
- Authors
- Diaz de Leon, A., Cronkhite, J. T., Katzenstein, A.-L. A., Godwin, J. D., Raghu, G., Glazer, C. S., Rosenblatt, R. L., Girod, C. E., Garrity, E. R., Xing, C., & Garcia, C. K.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- SUNY Upstate Medical University (US)
- University of Washington Medical Center (US)
- University of Chicago (US)
- Corresponding author
- Garcia, Christine Kim
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-05-19
- Volume
- 5
- Issue
- 5
- Pages
- e10680
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC2873288
- OpenAlex
- W2035774221
- Cited by
- 377
- References
- 35
- Citations by year
- 2026: 13 · 2025: 18 · 2024: 22 · 2023: 22 · 2022: 27 · 2021: 24 · 2020: 24 · 2019: 27 · 2018: 34 · 2017: 23 · 2016: 22 · 2015: 23 · 2014: 24 · 2013: 31 · 2012: 25
- FWCI
- 16.01
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Knowledge@UChicago (University of Chicago) (submittedVersion, cc-by-nc-nd)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Doris Duke Charitable Foundation
- American Heart Association
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R01HL093096)
- National Center for Research Resources (K23RR020632)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Keywords
- telomere length, idiopathic pulmonary fibrosis, TERT mutation, telomerase, telomeropathies, epigenetic inheritance, usual interstitial pneumonia, cigarette smoking, dyskeratosis congenita, germline mutations, age-dependent phenotype, survival
- MeSH terms
- Adult, Aged, Aged, 80 and over, Family, Female, Heterozygote, Humans, Male, Middle Aged, Mutation, Pedigree, Phenotype, Pulmonary Fibrosis, Radiography, Respiratory Function Tests, Smoking, Telomere, Telomerase, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.